OQS
HAE icon

Occudo Quantitative Strategies’s Haemonetics HAE Stock Holding History

Occudo Quantitative Strategies’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,964
Closed -$475K – 1204
2021
Q4 		$475K Buy
+8,964
New +$546K 0.04% 627

Other funds holding HAE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

Occudo Quantitative Strategies's HAE Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of Haemonetics (HAE) in Q1 2022, closing a stake of 8,964 shares — an estimated $475K sold.

Occudo Quantitative Strategies first reported a position in HAE in Q4 2021 and held it in 1 quarter. The position peaked at $475K in Q4 2021. 242 funds tracked by Wall St. Rank hold HAE as of Q1 2022.

  • Occudo Quantitative Strategies reported no remaining Haemonetics position as of Q1 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 8,964 Haemonetics shares in Q1 2022, an estimated $475K.
  • Occudo Quantitative Strategies first reported a position in Haemonetics in Q4 2021 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Haemonetics position peaked at $475K in Q4 2021.
  • 242 funds tracked by Wall St. Rank held Haemonetics as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.